SCHEMBL22473948

SCHEMBL22473948

NNC(=O)c1cc(N)cs1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.66
LMNA P02545 2/20 0.66
GAA P10253 7/20 0.44
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
S100A4 P26447 1/20 0.37
MAPT P10636 7/20 0.36
KDM4E B2RXH2 5/20 0.36
POLB P06746 3/20 0.36
NSD2 O96028 1/20 0.36
ALPL P05186 1/20 0.36
ALPI P09923 1/20 0.36
ALPG P10696 1/20 0.36
APEX1 P27695 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23493619 0.79 ALDH1A1 (1.00) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL29399720 0.78 ALDH1A1 (0.63) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL5436576 0.78 ALDH1A1 (0.63) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL1828771 0.76
SCHEMBL234370 0.73 CTPS1 (0.42) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL12261095 0.73 GSK3B (0.41) ALDH1A1LMNAKMT2AMEN1CYP3A4
Bromide SCHEMBL17201605 0.72 CTPS1 (0.41) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL6694136 0.72 ALDH1A1 (0.56) ALDH1A1LMNAGAAKMT2AMEN1
SCHEMBL22473949 0.70 KDM4E (0.48) ALDH1A1LMNAGAAMAPTKDM4E
SCHEMBL6691527 0.70 ALDH1A1 (0.53) ALDH1A1LMNAGAAMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10787435-B2 ASK1 inhibitor and preparation method and use thereof Fuijan Cosunter Pharmaceutical Co. Ltd. (CN) 2020-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10787435-B2 ASK1 inhibitor and preparation method and use thereof MARK1, MAP3K1, MAP3K20 ALDH1A1 3134/4885LMNA 2221/4885GAA 1572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.